Clinical Trials in Cleveland

Showing 5321-5340 of 19,775 trials

CLOSM Trial: Groin Closure Using Layered Option for Suture Material

NCT06990425

This is a randomized controlled trial comparing groin closure after vascular intervention with Vicryl suture versus PDS (polydioxanone) suture. This will be a single center trail performed at CCF main campus. Patients will be enrolled in a prospective fashion and will be randomized 1:1 to either PDS or Vicryl closure. Patients undergoing bilateral groin exposure will be randomized to receive both closure types to either groin.

Vascular Diseases

The Cleveland Clinic259 participantsStarted Mar 2025

Cleveland, Ohio, United States

COMPLETEDPhase 3< 1 mile

Randomized Therapy In Status Epilepticus

NCT04391569

This study evaluated the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).

Status Epilepticus

Marinus Pharmaceuticals100 participantsStarted Dec 2020

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +71 more locations

CLOSM Trial: Groin Closure Using Layered Option for Suture Material

Randomized Therapy In Status Epilepticus

Find Trials by Condition in Cleveland

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older Adults

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)